A clinical report on high‑dose cytarabine therapy for children with acute myeloid leukemia

Despite improvement in the long-term survival rate following pediatric acute myeloid leukemia (AML), the rate remains low, even with optimal treatment. The present study reports the long-term outcome of a small patient group treated with a single drug, high-dose chemotherapy (HDCT) with cytarabine,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ziliang, Wu, Zelin, Zou, Yawei, Guan, Jingming, Wu, Shangzhi, Chen, Dehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618839/
https://www.ncbi.nlm.nih.gov/pubmed/36325296
http://dx.doi.org/10.3892/mco.2022.2589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618839/
https://www.ncbi.nlm.nih.gov/pubmed/36325296
http://dx.doi.org/10.3892/mco.2022.2589

Ejemplares similares